This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lavine, J. A. Articles by Attie, A. D. Search for Related Content PubMed PubMed Citation Articles by Lavine, J. A. Articles by Attie, A. D.

Overexpression of Pre-Pro-Cholecystokinin Stimulates β-Cell Proliferation in Mouse and Human Islets with Retention of Islet Function

Department of Biochemistry (J.A.L., P.W.R., D.B.D., M.E.R., M.P.K., A.D.A.), and Department of Medicine (D.B.D.), University of Wisconsin-Madison, Madison, Wisconsin 53706; Sarah W. Stedman Nutrition and Metabolism Center and Department of Pharmacology and Cancer Biology (B.K.P., C.B.N.), Duke University Medical Center, Durham, North Carolina 27704; and Department of Pharmacology (M.C.B.), Tufts University, and Molecular Pharmacology Research Center (A.S.K.), Tufts Medical Center, Medford, Massachusetts 02111

Address all correspondence and requests for reprints to: Alan D. Attie, 433 Babcock Drive, Room 543A, Madison, Wisconsin 53706. E-mail: adattie{at}wisc.edu.

Type 1 and type 2 diabetes result from a deficit in insulin production and β-cell mass. Methods to expand β-cell mass are under intensive investigation for the treatment of type 1 and type 2 diabetes. We tested the hypothesis that cholecystokinin (CCK) can promote β-cell proliferation. We treated isolated mouse and human islets with an adenovirus containing the CCK cDNA (AdCMV-CCK). We measured [³H]thymidine and BrdU incorporation into DNA and additionally, performed flow cytometry analysis to determine whether CCK overexpression stimulates β-cell proliferation. We studied islet function by measuring glucose-stimulated insulin secretion and investigated the cell cycle regulation of proliferating β-cells by quantitative RT-PCR and Western blot analysis. Overexpression of CCK stimulated [³H]thymidine incorporation into DNA 5.0-fold and 15.8-fold in mouse and human islets, respectively. AdCMV-CCK treatment also stimulated BrdU incorporation into DNA 10-fold and 21-fold in mouse and human β-cells, respectively. Glucose-stimulated insulin secretion was unaffected by CCK expression. Analysis of cyclin and cdk mRNA and protein abundance revealed that CCK overexpression increased cyclin A, cyclin B, cyclin E, cdk1, and cdk2 with no change in cyclin D1, cyclin D2, cyclin D3, cdk4, or cdk6 in mouse and human islets. Additionally, AdCMV-CCK treatment of CCK receptor knockout and wild-type mice resulted in equal [³H]thymidine incorporation. CCK is a β-cell proliferative factor that is effective in both mouse and human islets. CCK triggers β-cell proliferation without disrupting islet function, up-regulates a distinct set of cell cycle regulators in islets, and signals independently of the CCK receptors.